[Head and neck cancers. What's new in clinical oncology for the practicing ENT physician?].
An interdisciplinary evaluation is made of the most common forms of head and neck cancer, with emphasis on certain aspects.--In the field of x-ray diagnostics, computed tomography dominates varying importance being given to the individual organs. Nuclear medicine pays particular attention to skeletal scintigraphy and gallium scintigraphy. In radiation therapy, progress has been made especially through the use of optimal radiation planning as well as the use of the after-loading technique and neutron radiation. Antineoplastic chemotherapy is currently being used as palliative treatment, adjuvant chemotherapy and as the first step towards a curative therapy.
D000970:Antineoplastic Agents / Q000008:administration & dosage; D001918:Brachytherapy / Q000295:instrumentation; D005710:Gallium Radioisotopes; D006258:Head and Neck Neoplasms / Q000175:diagnosis / Q000473:pathology / Q000628:therapy*; D006801:Humans; D009367:Neoplasm Staging; D011379:Prognosis; D011879:Radiotherapy Dosage; D014057:Tomography, X-Ray Computed
D000970:Antineoplastic Agents; D005710:Gallium Radioisotopes
Kopf-Hals-Karzinome. Was gibt es Neues in der Klinischen Onkologie für den praktizierenden Hals-Nasen-Ohren-Arzt?